These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 9658384)

  • 21. The PGI2-analogue iloprost and the TXA2-receptor antagonist sulotroban synergistically inhibit TXA2-dependent platelet activation.
    Stürzebecher S; Witt W
    Prostaglandins; 1988 Dec; 36(6):751-60. PubMed ID: 2469101
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prostaglandin F2 alpha isopropyl ester versus iloprost phenacyl ester in rabbit and beagle eyes.
    Groeneboer MC; Hoyng PF; Kuizenga A
    Curr Eye Res; 1989 Feb; 8(2):131-8. PubMed ID: 2540937
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of verapamil and iloprost (ZK 36374) on endothelin release after mesenteric ischemia-reperfusion injury.
    Yeğen C; Aktan AO; Büyükgebiz O; Haklar G; Yalçin AS; Yalin R; Ercan S
    Eur Surg Res; 1994; 26(2):69-75. PubMed ID: 7516292
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dissociation of antiplatelet effects from myocardial cytoprotective activity during acute myocardial ischemia in cats by a new carbacyclin derivative (ZK 36 375).
    Schrör K; Darius H; Ohlendorf R; Matzky R; Klaus W
    J Cardiovasc Pharmacol; 1982; 4(4):554-61. PubMed ID: 6181328
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early and late administration of a PGI2-analogue, ZK 36 374 (iloprost): effects on myocardial preservation, collateral blood flow and infarct size.
    Smith EF; Gallenkämper W; Beckmann R; Thomsen T; Mannesmann G; Schrör K
    Cardiovasc Res; 1984 Mar; 18(3):163-73. PubMed ID: 6200229
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Postischemic hyperemia in subjects with lower limbs obstructive arteriopathy: role of PGI2 and endothelin.
    Pancera P; Minuz P; Rossi L; Ribul M; Arosio E; Lechi A
    Angiology; 1997 Feb; 48(2):149-55. PubMed ID: 9040270
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of a stable prostacyclin analogue on platelet activity and on host immunocompetence in mice.
    Costantini V; Fuschiotti P; Giampietri A; Allegrucci M; Agnelli G; Nenci GG; Fioretti MC
    Prostaglandins; 1990 Jun; 39(6):581-99. PubMed ID: 1695382
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synergistic platelet inhibitory effect of the phosphodiesterase inhibitor piroximone and iloprost.
    Buerke M; Dieterich HA; Meyer J; Darius H
    Agents Actions Suppl; 1992; 37():71-7. PubMed ID: 1378692
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Systemic sclerosis-related Raynaud's phenomenon: effects of iloprost infusion therapy on serum cytokine, growth factor and soluble adhesion molecule levels.
    Mittag M; Beckheinrich P; Haustein UF
    Acta Derm Venereol; 2001; 81(4):294-7. PubMed ID: 11720181
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Organic nitrates and compounds that increase intraplatelet cyclic guanosine monophosphate (cGMP) levels enhance the antiaggregating effects of the stable prostacyclin analogue iloprost.
    Anfossi G; Massucco P; Mularoni E; Cavalot F; Mattiello L; Trovati M
    Prostaglandins Leukot Essent Fatty Acids; 1993 Nov; 49(5):839-45. PubMed ID: 7508131
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of morphological changes after treatment with coenzyme Q10 (CoQ10) in endothelin-1 induced experimental ischemia in the rat.
    Ostrowski RP; Piotrowski P; Pańkowska T; Smiałek M
    Folia Neuropathol; 1998; 36(3):185-8. PubMed ID: 9833395
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Iloprost ameliorates post-ischemic lung reperfusion injury and maintains an appropriate pulmonary ET-1 balance.
    Kawashima M; Nakamura T; Schneider S; Vollmar B; Lausberg HF; Bauer M; Menger MD; Schäfers HJ
    J Heart Lung Transplant; 2003 Jul; 22(7):794-801. PubMed ID: 12873548
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of the stable prostacyclin analogue ZK 36374 on experimental coronary thrombosis in the pig.
    van der Giessen WJ; Mooi WJ; Rutteman AM; Berk L; Verdouw PD
    Thromb Res; 1984 Oct; 36(1):45-51. PubMed ID: 6209820
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nitric oxide and prostacyclin modulate the alterations in cardiac action potential duration mediated by platelets during ischaemia.
    Goulielmos NV; Enayat ZE; Sheridan DJ; Cohen H; Flores NA
    Cardiovasc Res; 1995 Nov; 30(5):788-98. PubMed ID: 8595628
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Experimental cerebral vasospasm: resolution by iloprost.
    Egemen N; Birler K; Avman N; Türker RK
    Acta Neurochir (Wien); 1988; 95(3-4):131-5. PubMed ID: 2465677
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of prostacyclin and of the stable prostacyclin analogue ZK 36374 on forearm blood flow and blood platelet behaviour in man.
    Cowley AJ; Heptinstall S; Hampton JR
    Thromb Haemost; 1985 Feb; 53(1):90-4. PubMed ID: 2581332
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of Iloprost (ZK 36 374), a novel prostacyclin analogue, on ADP-induced platelet aggregation.
    Wadenvik H; Kutti J
    Acta Haematol; 1985; 73(4):224-7. PubMed ID: 2414956
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibitory effects of ZK 36374, a stable prostacyclin analogue, on adhesion of rabbit platelets to damaged aorta and serotonin release by adherent platelets.
    Menys VC; Davies JA
    Clin Sci (Lond); 1983 Aug; 65(2):149-53. PubMed ID: 6190604
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics of tissue-type plasminogen activator during acute myocardial infarction in men. Effect of a prostacyclin analogue.
    Kerins DM; Roy L; Kunitada S; Adedoyin A; FitzGerald GA; Fitzgerald DJ
    Circulation; 1992 Feb; 85(2):526-32. PubMed ID: 1370924
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [3-[4-(4,5-Diphenyl-2-oxazolyl)-5-oxazolyl]phenoxy]acetic acid (BMY 45778) is a potent non-prostanoid prostacyclin partial agonist: effects on platelet aggregation, adenylyl cyclase, cAMP levels, protein kinase, and iloprost binding.
    Seiler SM; Brassard CL; Federici ME; Romine J; Meanwell NA
    Prostaglandins; 1997 Jan; 53(1):21-35. PubMed ID: 9068064
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.